127 related articles for article (PubMed ID: 38317537)
21. p53 immunostaining in lichen sclerosus is related to ischaemic stress and is not a marker of differentiated vulvar intraepithelial neoplasia (d-VIN).
Liegl B; Regauer S
Histopathology; 2006 Feb; 48(3):268-74. PubMed ID: 16430473
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas.
Campos MA; Macedo S; Fernandes MS; Pestana A; Pardal J; Batista R; Vinagre J; Sanches A; Baptista A; Lopes JM; Soares P
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32640663
[No Abstract] [Full Text] [Related]
23. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
Cain CT; Niemann TH; Argenyi ZB
Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
[TBL] [Abstract][Full Text] [Related]
24. Performance of the pattern-based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinoma.
Kortekaas KE; Solleveld-Westerink N; Tessier-Cloutier B; Rutten TA; Poelgeest MIE; Gilks CB; Hoang LN; Bosse T
Histopathology; 2020 Jul; 77(1):92-99. PubMed ID: 32236967
[TBL] [Abstract][Full Text] [Related]
25. Expression of human telomerase reverse transcriptase in vulvar intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study with survivin and p53.
Wellenhofer A; Brustmann H
Arch Pathol Lab Med; 2012 Nov; 136(11):1359-65. PubMed ID: 23106581
[TBL] [Abstract][Full Text] [Related]
26. P53, p16 and Ki67 immunoexpression in cutaneous squamous cell carcinoma and its precursor lesions.
Marinescu A; Stepan AE; Mărgăritescu C; Marinescu AM; Zăvoi RE; Simionescu CE; Niculescu M
Rom J Morphol Embryol; 2016; 57(2 Suppl):691-696. PubMed ID: 27833960
[TBL] [Abstract][Full Text] [Related]
27. Carcinogenesis of Vulvar Lesions: Morphology and Immunohistochemistry Evaluation.
Rivero RC; Garcia D; Hammes LS; Cerski MR; Magno V; Kliemann LM; Capp E
J Low Genit Tract Dis; 2017 Jan; 21(1):73-77. PubMed ID: 28027121
[TBL] [Abstract][Full Text] [Related]
28. Time series analysis of TP53 gene mutations in recurrent HPV-negative vulvar squamous cell carcinoma.
Regauer S; Kashofer K; Reich O
Mod Pathol; 2019 Mar; 32(3):415-422. PubMed ID: 30291345
[TBL] [Abstract][Full Text] [Related]
29. Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression.
Yang B; Hart WR
Am J Surg Pathol; 2000 Mar; 24(3):429-41. PubMed ID: 10716158
[TBL] [Abstract][Full Text] [Related]
30. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia.
Carlson JA; Ambros R; Malfetano J; Ross J; Grabowski R; Lamb P; Figge H; Mihm MC
Hum Pathol; 1998 Sep; 29(9):932-48. PubMed ID: 9744309
[TBL] [Abstract][Full Text] [Related]
31. [ASSOCIATION OF SKIN PHOTOTYPE AND UV EXPOSURE WITH EXPRESSION OF HER RECEPTORS, Ki67 AND p53 IN PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMA].
Drvar DL; Lipozenčić J; Mokos ZB; Ilić I; Knežević F
Acta Med Croatica; 2015; 69(5):431-8. PubMed ID: 29087088
[TBL] [Abstract][Full Text] [Related]
32. High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva.
van der Avoort IA; van de Nieuwenhof HP; Otte-Höller I; Nirmala E; Bulten J; Massuger LF; van der Laak JA; Slootweg PJ; de Hullu JA; van Kempen LC
Hum Pathol; 2010 Oct; 41(10):1475-85. PubMed ID: 20656324
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical expression of p16 and p53 in vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva.
Nogueira MC; Guedes Neto Ede P; Rosa MW; Zettler E; Zettler CG
Pathol Oncol Res; 2006; 12(3):153-7. PubMed ID: 16998595
[TBL] [Abstract][Full Text] [Related]
34. Squamous proliferations on the legs of women: Qualitative examination of histopathology, TP53 sequencing, and implications for diagnosis in a series of 30 cases.
Ko CJ; Glusac EJ; McNiff JM; Rodic N; Leffell DJ
J Am Acad Dermatol; 2017 Dec; 77(6):1126-1132.e1. PubMed ID: 28709693
[TBL] [Abstract][Full Text] [Related]
35. HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulva.
Parra-Herran C; Nucci MR; Singh N; Rakislova N; Howitt BE; Hoang L; Gilks CB; Bosse T; Watkins JC
Mod Pathol; 2022 Oct; 35(10):1317-1326. PubMed ID: 35437330
[TBL] [Abstract][Full Text] [Related]
36. Claudin and p53 expression in vulvar lichen sclerosus and squamous-cell carcinoma.
Sadalla JC; Lourenço SV; Sotto MN; Baracat EC; Carvalho JP
J Clin Pathol; 2011 Oct; 64(10):853-7. PubMed ID: 21642657
[TBL] [Abstract][Full Text] [Related]
37. Molecular events in the pathogenesis of vulvar squamous cell carcinoma.
Xing D; Fadare O
Semin Diagn Pathol; 2021 Jan; 38(1):50-61. PubMed ID: 33032902
[TBL] [Abstract][Full Text] [Related]
38. GATA3 immunohistochemistry as a diagnostic adjunct for differentiated vulvar intraepithelial neoplasia: utility and limitations.
Zare SY; Fard EV; Fadare O
Hum Pathol; 2023 Sep; 139():55-64. PubMed ID: 37454993
[TBL] [Abstract][Full Text] [Related]
39. p53/CK17 Dual Stain Improves Accuracy of Distinction Between Differentiated Vulvar Intraepithelial Neoplasia and Its Mimics.
McMullen-Tabry ER; Schechter SA; Wang GY; Sciallis AP; Hrycaj SM; Chan MP; Skala SL
Int J Gynecol Pathol; 2022 May; 41(3):298-306. PubMed ID: 35444146
[TBL] [Abstract][Full Text] [Related]
40. The Histologic and Molecular Spectrum of Highly Differentiated HPV-independent Cervical Intraepithelial Neoplasia.
Regauer S; Reich O
Am J Surg Pathol; 2023 Aug; 47(8):942-949. PubMed ID: 37283469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
